GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 181 filers reported holding GW PHARMACEUTICALS PLC in Q3 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,625,000 | +295.4% | 7,491 | +77.3% | 0.01% | +66.7% |
| Q3 2020 | $411,000 | -57.1% | 4,225 | -45.9% | 0.01% | -60.0% |
| Q2 2020 | $958,000 | +38.4% | 7,805 | -1.2% | 0.02% | -16.7% |
| Q1 2020 | $692,000 | +7.6% | 7,902 | +28.5% | 0.02% | +350.0% |
| Q4 2019 | $643,000 | -81.9% | 6,148 | -80.1% | 0.00% | -87.5% |
| Q3 2019 | $3,552,000 | -47.2% | 30,876 | -20.9% | 0.03% | -51.5% |
| Q2 2019 | $6,726,000 | +962.6% | 39,016 | +939.6% | 0.07% | +842.9% |
| Q1 2019 | $633,000 | -22.9% | 3,753 | -55.5% | 0.01% | -30.0% |
| Q4 2018 | $821,000 | +9.8% | 8,435 | +94.7% | 0.01% | +11.1% |
| Q3 2018 | $748,000 | +256.2% | 4,332 | +109.5% | 0.01% | +125.0% |
| Q3 2017 | $210,000 | – | 2,068 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 602,047 | $61,102,000 | 6.76% |
| FT Options LLC | 36,847 | $3,740,000 | 5.64% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,988,019 | $303,254,000 | 4.80% |
| FT Options LLC | 71,000 | $1,320,000 | 1.99% |
| Rock Springs Capital Management LP | 373,000 | $37,856,000 | 1.75% |
| Redmile Group, LLC | 338,536 | $34,358,000 | 1.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 362,724 | $36,813,000 | 1.66% |
| Ghost Tree Capital, LLC | 50,000 | $5,075,000 | 1.08% |
| Atika Capital Management LLC | 32,500 | $3,298,000 | 0.95% |
| Sivik Global Healthcare LLC | 25,000 | $2,537,000 | 0.86% |